Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors, Primitive, Peripheral

Explore clinical trials studying Neuroectodermal Tumors, Primitive, Peripheral. Study availability and eligibility vary by location and protocol.

501 public trials 99 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors, Primitive, Peripheral trial results

Active, Not Recruiting

Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells

NCT02573896

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus Atlanta, Georgia, United States
  • University of Chicago Comer Children's Hospital Chicago, Illinois, United States
View Trial Details
Active, Not Recruiting

Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory Neuroblastoma

NCT02298348

Conditions
Disease Attributes, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • UCSF Comprehensive Cancer Center San Francisco, California, United States
  • Children Hospital of Colorado Aurora, Colorado, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
View Trial Details
Active, Not Recruiting

Neuroblastoma Precision Trial

NCT02868268

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Children Hospital of Colorado Aurora, Colorado, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
View Trial Details
Active, Not Recruiting

Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas

NCT03478462

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +62 more
Locations
  • Lucile Packard Children's Hospital Palo Alto, California, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Duke University Chapel Hill, North Carolina, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details
Active, Not Recruiting

Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors

NCT02574728

Conditions
Brain Diseases, Brain Neoplasms, Cancer, +38 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Nemours/Alfred I. duPont Hospital for Children Wilmington, Delaware, United States
  • Children's Healthcare of Atlanta-Egleston Atlanta, Georgia, United States
  • Children's Healthcare of Atlanta, Scottish Rite Atlanta, Georgia, United States
View Trial Details
Active, Not Recruiting

Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma

NCT03794349

Conditions
High Risk Neuroblastoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
  • Miller Children's and Women's Hospital Long Beach Long Beach, California, United States
View all 145 locations
View Trial Details
Active, Not Recruiting

Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma

NCT03057626

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +13 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
View all 98 locations
View Trial Details

Related conditions